Supportive conversations for self-care in pulmonary fibrosis
Part of Lungs & breathing clinical trials.
This study tests a program called motivational interviewing, which uses supportive conversations to help you build self-care habits. It aims to see if this program can improve your daily life with IPF.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of IPF for at least one year.
- You are 18 years old or older.
- You are able to provide consent to participate.
- You have access to a device like a smartphone, tablet, or computer with internet.
- You can speak, read, and write in Italian.
- You do not have dementia, severe vision or hearing loss, or advanced oxygen needs (10–15 L/min).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether an oral medication (INS018_055) can help people with idiopathic pulmonary fibrosis (IPF). You may be a fit if your lung function is in a certain range and your condition is stable.
This study tests whether a smartphone app called FORTISKAP helps people stick to their oral medications for lung conditions like interstitial lung disease and pulmonary hypertension. If you join, you'll either use the app or receive usual care, and the goal is to see if the app improves medication routines and outcomes.
This study uses safe, painless scans (like muscle ultrasound and a body composition test) to track changes in muscle and fat in patients with IPF or PPF who are starting anti-fibrotic medication. The goal is to better understand how these treatments affect your body.
This study looks at the symptoms and patterns of idiopathic pulmonary fibrosis (IPF), a lung condition that causes scarring. By joining, you help doctors better understand the disease, which may lead to better care.
This study tests a learning and self-management program for people with pulmonary fibrosis. It helps you better understand and manage your lung condition.
This study tests a counseling program to help people with interstitial lung disease (a group of lung conditions that cause scarring and make breathing harder) with rehabilitation and support. It may help you cope better and stay active.
Hear when a new Idiopathic Pulmonary Fibrosis (IPF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.